Multiple Sclerosis - News

Reuters Logo

FDA says unsure if Novartis MS pill caused deaths

U.S. health regulators said on Monday they could not definitively link Novartis AG's multiple sclerosis pill Gilenya with...

Marijuana may ease multiple sclerosis symptoms

People with multiple sclerosis have long said that smoking marijuana helps ease their painful muscle cramping. And a new...

FDA warns MS patients about risky stent treatment

U.S. drug regulators are warning people with multiple sclerosis to avoid an experimental treatment that props open internal...

Connecticut Senate passes medical marijuana bill

The Connecticut Senate passed a bill on Saturday legalizing marijuana use for medical purposes with tight restrictions aimed...

Fish oil supplements don't help MS patients: study

Many people with multiple sclerosis take fish oil pills with the hope of keeping neurological symptoms from getting worse,...

New warnings on Novartis MS pill in Europe and U.S.

European and U.S. regulators have backed the continued use of Novartis AG's multiple sclerosis pill Gilenya, one of the Swiss...

Novartis MS pill patient diagnosed with rare illness

A patient taking Novartis's multiple sclerosis pill Gilenya developed a rare and often fatal viral disease, the Swiss drugmaker...

EU says Novartis MS drug needs heart monitoring

The European Medicines Agency advised doctors to continuously monitor patients for six hours after giving them a first dose...

FDA looking into death of patient on MS drug

U.S. health regulators said on Tuesday they received a report of a multiple sclerosis patient who died within 24 hours of...

Gilenya trial could ease safety worries

A third late-stage trial of Novartis' multiple sclerosis drug Gilenya did not throw up any new safety issues with the pill,...

Blood vessel condition tied to MS, with caveats

A new analysis of past studies concludes that there seems to be some link between multiple sclerosis and narrowed head and...

Nobel prizewinner dies before announcement

A scientist who won the Nobel prize for medicine on Monday for work on fighting cancer died of the disease himself just three...

Nobel medicine prize honours work on body's defences

Three scientists who unlocked secrets of the body's immune system, opening doors to new vaccines and cancer treatments, won...

Multiple sclerosis patient finishes 50th marathon

Life has taken long-distance runner Patrick Finney down many paths, but few have been so rewarding as the one that led him...

Migraines are not a lupus symptom: study

Despite a commonly-held belief among many doctors who treat lupus patients, headaches -- particularly migraines -- are not...

Scientists unravel genetic clues to MS

Scientists have found 29 new genetic variants linked to multiple sclerosis (MS) and say the findings should help drugmakers...

No link between MS, narrow blood vessels: study

A new study provides more evidence that multiple sclerosis (MS) is not caused by a blood vessel condition, as some research...

UK cost watchdog says 'No' to Novartis MS pill

Novartis's multiple sclerosis pill Gilenya, one of its biggest new drug hopes, has been rejected by Britain's healthcare...

REFILE: Benefit of MS drugs comes at steep price: study

Drugs used in the hope of slowing multiple sclerosis progression may help some patients, but at a very high cost, according...

Benefit of MS drugs comes at steep price: study

Drugs used in the hope of slowing multiple sclerosis progression may help some patients, but at a very high cost, according...

Breastfeeding may not stop MS flare-ups: study

Some studies have suggested that breastfeeding might offer women with multiple sclerosis a way to prevent symptom flare-ups...

Montana judge blocks new curbs on medical marijuana

A judge has blocked parts of a Montana law that would have imposed tough new restrictions on state-sanctioned medical marijuana...

Multiple sclerosis linked to shingles

People who get shingles are more likely to also develop multiple sclerosis, according to a study in Taiwan. Researchers found...

Stress doesn't raise risk of MS: study

Having a stressful home or work environment doesn't make a person more likely to develop multiple sclerosis, hints a large...

Sun exposure and vitamin D linked to MS risk

People who have spent more time in the sun and those with higher vitamin D levels may be less likely to develop multiple...

Elan, Biogen ask for virus issue on Tysabri label

Elan and Biogen Idec have asked regulators for a green light to change the label on the multiple sclerosis drug Tysabri (natalizumab)...

Biogen reports four more Tysabri cases, one death

Four more patients taking Biogen Idec's multiple sclerosis drug Tysabri have developed the serious brain infection known...

Roche, Biogen report one death in MS drug trial

Roche Holding AG and Biogen Idec Inc reported data from a mid-stage trial of their experimental multiple sclerosis drug ocrelizumab...

Novartis MS pill to cost $48,000 per year

Swiss drugmaker Novartis AG said the average annual cost of its oral multiple sclerosis drug Gilenya will be $48,000 in the...

Body vibration therapy fails test in MS patients

Whole-body vibration is pitched as a solution to everything from low bone density in astronauts to a better golf swing for...

Copyright ©2012 Thomson Reuters. Click For Restrictions
Advertisement
 
 

Sign Up for Free Newsletters

View All Newsletters

Ask Your Doctor the RIGHT Questions!

Get FREE tools and tips to get
the most from your doctor visit.
Emailed right to you!

The Ask Your Doctor email series
may contain sponsored content.
18+, US residents only please.